The National Health Service has launched the first cancer trial of its kind –


Cancer is a dominant, uncontrollable disease that results in painful death. With the growing number of cancer patients, it is high time to think about the well-being of people with cancer. In the past year, this terrible disease is responsible for around 1 crore of deaths according to the World Health Organization. Many of the lost battles against cancer are due to the high cost of diagnosis and expensive treatments. In an effort to get a proper cure for this deadly disease, the National Health Service, a UK state organization, has launched a trial that may help lower the cost of diagnosis and treatment in several countries, including India. , further promoting good health and increasing the number of cancer survivors.

The NHS has started a process to bring relief to people with cancer. The world’s largest trial of Grail Inc’s flagship Galleri blood test will help detect 50 types of cancer before a person’s symptoms even appear. Plus, if the trial is successful, it will do wonders for cancer patients who suffer tremendous pain every day. The essay is the first of its kind and asks 140,000 people in eight different areas to verify the credibility of the test.

“Performed as a quick and easy blood test, ” NHS Executive Director Amanda Pritchard said, “This could mark the start of a revolution in cancer detection and treatment here and around the world. “

“By finding cancer before the signs and symptoms even appear, we have the best chance of treating it and we can give people the best chance of survival,” suggested Pritchard.

“What this means for India and even for the rest of the world is that the ongoing investigations will have a precursor, so their cost will drop dramatically for the investigations themselves,” said Dr Mamta Rao, radiologist. consultant in UK. .

Harriet Buckingham, who was first told about her breast cancer in 2013, said the trial would have made all the difference for her if her cancer had been caught early. “By the time I found my lump, the cancer had traveled to my lymph nodes. If my cancer had been caught earlier, maybe my treatment would have been less frightening, ”said Harriet, who is now fully recovered.

The National Cancer Registry Program in India said that out of 68 men, 1 man is likely to succumb to lung cancer, 1 in 29 women will have breast cancer and 1 in 9 Indians will have to live with cancer in their lifetime. . The cancer trial is expected to have a beneficial effect on some cancer patients that affect the head, neck, lungs, intestines, pancreas and throat.

Dr Preetha Arvind said: “This test works to detect earlier cancers that would not be detected routinely.” Further, “screening programs only detect certain types of tumors, but this could potentially detect cancers that do not have screening programs.”

Most men are prone to cancer of the oral cavity, lung, stomach, colorectal and esophagus. While women suffer from breast, oral cavity, neck, lung and stomach cancers. “The oral cavity, stomach and stomach are some of the cancers that do not yet have a screening program. Therefore, a blood test like this could be a game changer, ”said Dr Preeta Arvind.

The study shows that results are expected to be seen by 2023 and if the test is successful, the NHS will launch more scaled-up trials for around 1 million people through 2024 and 2025. And if all goes well as expected, the test will be available by 2026, said Dr Mamta Rao
Continue reading on The India Saga

Leave A Reply

Your email address will not be published.